Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Best

Showing results (1181-1190 of 1,265) with videos related to

Pageof 127
Sort By:
Bioorganic & Medicinal Chemistry|March 7, 2013
Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruziMartine Keenan, Paul W Alexander, Hugo Diao, et al.
Nature Communications|June 25, 2013
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growthLei Wang, Jianjun Chang, Diana Varghese, et al.
Clinical Pharmacokinetics|November 12, 2025
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and PostpartumYifan Yu, Kristina M Brooks, Gustavo F Doncel, et al.
Journal of Strength and Conditioning Research|December 9, 2014
Long-term athletic development- part 1: a pathway for all youthRhodri S Lloyd, Jon L Oliver, Avery D Faigenbaum, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 23, 2022
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026sKristina M Brooks, Mauricio Pinilla, Alice M Stek, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methodsL M Best, D J M Haldane, M Keelan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 18, 2021
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)H James Wedner, Emel Aygören-Pürsün, Jonathan Bernstein, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2020
Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURBLaura M Best, Belinda Williams, Bernard Le Foll, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2025
Pharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their InfantsKathleen M Powis, Mauricio Pinilla, Flynn McMorrow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2012
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovirBrookie M Best, Scott L Letendre, Peter Koopmans, et al.
Pageof 127

Showing results (1181-1190 of 1,265) with videos related to

Sort By:
Pageof 127
Bioorganic & Medicinal Chemistry|March 7, 2013
Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruziMartine Keenan, Paul W Alexander, Hugo Diao, et al.
Nature Communications|June 25, 2013
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growthLei Wang, Jianjun Chang, Diana Varghese, et al.
Clinical Pharmacokinetics|November 12, 2025
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and PostpartumYifan Yu, Kristina M Brooks, Gustavo F Doncel, et al.
Journal of Strength and Conditioning Research|December 9, 2014
Long-term athletic development- part 1: a pathway for all youthRhodri S Lloyd, Jon L Oliver, Avery D Faigenbaum, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 23, 2022
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026sKristina M Brooks, Mauricio Pinilla, Alice M Stek, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methodsL M Best, D J M Haldane, M Keelan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 18, 2021
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)H James Wedner, Emel Aygören-Pürsün, Jonathan Bernstein, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2020
Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURBLaura M Best, Belinda Williams, Bernard Le Foll, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2025
Pharmacokinetics and Safety of Bictegravir in Pregnant and Postpartum Persons With HIV and Their InfantsKathleen M Powis, Mauricio Pinilla, Flynn McMorrow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2012
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovirBrookie M Best, Scott L Letendre, Peter Koopmans, et al.
Pageof 127